Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/19 (What's New)

Summary

  • Zidovudine is currently indicated for treatment of HIV infection in combination with other antiretroviral agents and prevention of mother-to-child transmission of HIV[FDA Zidovudine]
  • It is indicated for treatment-naive and treatment-experienced patients
  • Administered orally at 300 mg twice daily

    Action required

    Keywords: Hematologic Malignancies, Initial Antiretroviral Therapy, Management of Treatment-Experienced Patients, Pregnancy, Special Populations, Treatment Complications

    ©2018 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.